These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15248376)

  • 21. Association of DLG5 and inflammatory bowel disease across populations.
    Tenesa A; Noble C; Satsangi J; Dunlop M
    Eur J Hum Genet; 2006 Mar; 14(3):259-60; author reply 260-1. PubMed ID: 16391570
    [No Abstract]   [Full Text] [Related]  

  • 22. [Inflammatory bowel disease: genotype-fenotype relationship].
    Gómez de la Concha E
    An R Acad Nac Med (Madr); 2006; 123(2):307-17; discussion 318-20. PubMed ID: 17310638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease.
    Papa A; Pola R; Flex A; Danese S; Armuzzi A; Gaetani E; Guidi L; De Vitis I; Urgesi R; Grillo A; Serricchio M; Proia AS; Fedeli G; Gasbarrini G; Pola P; Gasbarrini A
    Dig Liver Dis; 2004 Aug; 36(8):528-32. PubMed ID: 15334773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined evidence from three large British Association studies rejects TUCAN/CARD8 as an IBD susceptibility gene.
    Fisher SA; Mirza MM; Onnie CM; Soars D; Lewis CM; Prescott NJ; Mathew CG; Sanderson J; Forbes A; Todhunter C; Donaldson P; Mansfield J
    Gastroenterology; 2007 May; 132(5):2078-80. PubMed ID: 17484911
    [No Abstract]   [Full Text] [Related]  

  • 27. No association between the TUCAN (CARD8) Cys10Stop mutation and inflammatory bowel disease in a large retrospective German and a clinically well-characterized Norwegian sample.
    Franke A; Rosenstiel P; Balschun T; Von Kampen O; Schreiber S; Sina C; Hampe J; Karlsen TH; Vatn MH; ; Solberg C
    Gastroenterology; 2007 May; 132(5):2080-1. PubMed ID: 17484912
    [No Abstract]   [Full Text] [Related]  

  • 28. [Genetic breakthrough in inflammatory bowel disease].
    Almer S
    Lakartidningen; 2001 Jun; 98(23):2795. PubMed ID: 11462272
    [No Abstract]   [Full Text] [Related]  

  • 29. Advances in the molecular dissection of inflammatory bowel disease.
    Siminovitch KA
    Semin Immunol; 2006 Aug; 18(4):244-53. PubMed ID: 16679026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of SLC11A1 as an inflammatory bowel disease candidate gene.
    Crawford NP; Eichenberger MR; Colliver DW; Lewis RK; Cobbs GA; Petras RE; Galandiuk S
    BMC Med Genet; 2005 Mar; 6():10. PubMed ID: 15757519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease.
    Seiderer J; Dambacher J; Leistner D; Tillack C; Glas J; Niess JH; Pfennig S; Jürgens M; Müller-Myhsok B; Göke B; Ochsenkühn T; Lohse P; Reinecker HC; Brand S
    Clin Immunol; 2008 Apr; 127(1):49-55. PubMed ID: 18248772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype/phenotype correlations and implications for clinical practice.
    Silverberg MS
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E4-5. PubMed ID: 18354327
    [No Abstract]   [Full Text] [Related]  

  • 33. Attitudes toward genetic testing in patients with inflammatory bowel disease.
    Lal S; Appelton J; Mascarenhas J; Stempak JM; Esplen MJ; Silverberg MS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):321-7. PubMed ID: 17353697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new hypothesis on inflammatory bowel diseases.
    El-Tawil AM
    Eur Rev Med Pharmacol Sci; 2009; 13(1):66; author reply 67. PubMed ID: 19364088
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases.
    Ahmed FE
    Expert Rev Mol Diagn; 2006 May; 6(3):345-63. PubMed ID: 16706738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical aspects of inflammatory bowel disease.
    Siegmund B; Zeitz M
    Eur J Immunol; 2009 Aug; 39(8):2026-30. PubMed ID: 19672897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coeliac disease and bowel disease: Business association or casual meeting?
    Villanacci V; Bassotti G
    Dig Liver Dis; 2010 Mar; 42(3):171-2. PubMed ID: 20122884
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetics of inflammatory bowel disease: population aspects.
    Hemminki K; Bermejo JL; Försti A
    Gastroenterology; 2008 Jun; 134(7):2190-1. PubMed ID: 18485911
    [No Abstract]   [Full Text] [Related]  

  • 40. Early onset IBD: what's the difference?
    Nieuwenhuis EE; Escher JC
    Dig Liver Dis; 2008 Jan; 40(1):12-5. PubMed ID: 17997370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.